Compounds > sumatriptan

Page last updated: 2024-08-16

sumatriptan and tegaserod

sumatriptan has been researched along with tegaserod in 6 studies

Research

Studies (6)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	3 (50.00)	29.6817
2010's	3 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Lombardo, F; Obach, RS; Waters, NJ	1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV	1
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Chan, KY; Danser, AH; de Vries, R; Leijten, FP; MaassenVanDenBrink, A; Pfannkuche, HJ; van den Bogaerdt, AJ	1
Bönisch, H; Haenisch, B	1

Reviews

1 review(s) available for sumatriptan and tegaserod

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016

Other Studies

5 other study(ies) available for sumatriptan and tegaserod

Article	Year
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Physicochemical determinants of human renal clearance. Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15 Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight	2009
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination. Journal of medicinal chemistry, 2010, Feb-11, Volume: 53, Issue:3 Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations	2010
Functional characterization of contractions to tegaserod in human isolated proximal and distal coronary arteries. European journal of pharmacology, 2009, Oct-01, Volume: 619, Issue:1-3 Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adolescent; Adult; Benzamides; Coronary Vessels; Female; Humans; In Vitro Techniques; Indoles; Male; Middle Aged; Muscle Contraction; Pyridines; Receptors, Serotonin, 5-HT4; RNA, Messenger; Serotonin 5-HT4 Receptor Agonists; Serotonin Receptor Agonists; Sumatriptan; Vasoconstrictor Agents; Young Adult	2009
Pharmacological characterization of tegaserod at the wild type and 124Cys variant of the human 5-HT1B receptor. Pharmacogenetics and genomics, 2011, Volume: 21, Issue:7 Topics: Adenylyl Cyclases; Animals; Cell Line, Tumor; Colforsin; Coronary Vessels; Cyclic AMP; Genetic Variation; Genotype; GTP-Binding Proteins; Humans; Indoles; Rats; Receptor, Serotonin, 5-HT1B; Serotonin 5-HT1 Receptor Agonists; Sumatriptan; Transfection	2011